Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Codex Participation Prohibited, Reps. Paul, DeFazio Maintain

This article was originally published in The Tan Sheet

Executive Summary

FDAMA prohibits FDA officials from participating in the Codex regulatory harmonization process for foods and dietary supplements, Reps. Ron Paul (R-Tex.) and Peter DeFazio (D-Ore.) state in a June 20 letter to HHS Secretary Tommy Thompson.

You may also be interested in...



Food, Supplement Health Claim Oversight Shift Urged In House Bill

FDA's authority to approve health claims for foods and dietary supplements would be removed under a bill introduced in the House Feb. 27 by Rep. Ron Paul (R-Texas)

Food, Supplement Health Claim Oversight Shift Urged In House Bill

FDA's authority to approve health claims for foods and dietary supplements would be removed under a bill introduced in the House Feb. 27 by Rep. Ron Paul (R-Texas)

Food, Supplement Health Claim Oversight Shift Urged In House Bill

FDA's authority to approve health claims for foods and dietary supplements would be removed under a bill introduced in the House Feb. 27 by Rep. Ron Paul (R-Texas)

Topics

UsernamePublicRestriction

Register

PS092710

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel